FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Masayuki Kurosaki

Research Profile

Living Beings

Hepacivirus

Concepts & Ideas

Disorders

Chemicals & Drugs

Genes & Molecular Sequences

Procedures

Polymerase Chain Reaction

Physiology

Co-author Network

Publications

TOP 3
Masayuki Kurosaki; Shinya Maekawa; Kentaro Matsuura; Masashi Mizokami; Mina Nakagawa; Nao Nishida; Minoru Sakamoto; Naoya Sakamoto; Yasuhito Tanaka; Katsushi Tokunaga; Mamoru Watanabe; Yasuhiro Asahina; Nobuyuki Enomoto; Namiki Izumi
Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C.
Namiki Izumi; Eiji Kajiwara; Kazuya Kariyama; Shinji Katsushima; Tsutomu Kawai; Masatoshi Kudo; Hiroshi Adachi; Yasuhiro Asahina; Kazuaki Chayama; Yoichi Hiasa; Mie Inao; Masayuki Kurosaki; Hisataka Moriwaki; Yukishige Okamura; Makoto Oketani; Kouichi Takaguchi; Takayuki Takeuchi; Eiji Tanaka; Joji Toyoda; Gotaro Yamada; Hiroshi Yatsuhashi; Osamu Yokosuka; Hiromitsu Kumada
Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study.
Namiki Izumi; Masayuki Kurosaki; Shoko Suzuki; Nobuharu Tamaki
[Triple therapy with direct acting antiviral agent, peginterferon and ribavirin for chronic hepatitis C].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Masayuki Kurosaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Masayuki Kurosaki; Shinya Maekawa; Kentaro Matsuura; Masashi Mizokami; Mina Nakagawa; Nao Nishida; Minoru Sakamoto; Naoya Sakamoto; Yasuhito Tanaka; Katsushi Tokunaga; Mamoru Watanabe; Yasuhiro Asahina; Nobuyuki Enomoto; Namiki Izumi
Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C.
Journal of medical virology 2013;85(3):449-58.
2013: Namiki Izumi; Eiji Kajiwara; Kazuya Kariyama; Shinji Katsushima; Tsutomu Kawai; Masatoshi Kudo; Hiroshi Adachi; Yasuhiro Asahina; Kazuaki Chayama; Yoichi Hiasa; Mie Inao; Masayuki Kurosaki; Hisataka Moriwaki; Yukishige Okamura; Makoto Oketani; Kouichi Takaguchi; Takayuki Takeuchi; Eiji Tanaka; Joji Toyoda; Gotaro Yamada; Hiroshi Yatsuhashi; Osamu Yokosuka; Hiromitsu Kumada
Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study.
Journal of gastroenterology 2013;48(3):382-90.
2012: Namiki Izumi; Masayuki Kurosaki; Shoko Suzuki; Nobuharu Tamaki
[Triple therapy with direct acting antiviral agent, peginterferon and ribavirin for chronic hepatitis C].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2012;109(12):2108-11.
2012: Masayuki Kurosaki; Kentaro Matsuura; Mina Nakagawa; Minoru Sakamoto; Naoya Sakamoto; Fuminaka Sugauchi; Yoshiyuki Suzuki; Akihiro Tamori; Naoki Hiramatsu; Manabu Iwasaki; Sei Kakinuma; Namiki Izumi
Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C.
Journal of hepatology 2012;56(3):602-8.
2012: Masayuki Kurosaki; Kentaro Matsuura; Mina Nakagawa; Minoru Sakamoto; Naoya Sakamoto; Fuminaka Sugauchi; Yoshiyuki Suzuki; Akihiro Tamori; Hiroshi Yatsuhashi; Naoki Hiramatsu; Manabu Iwasaki; Sei Kakinuma; Namiki Izumi
Age and total ribavirin dose are independent predictors of relapse after interferon therapy in chronic hepatitis C revealed by data mining analysis.
Antiviral therapy 2012;17(1):35-43.
2011: Naoki Hiramatsu; Manabu Iwasaki; Sei Kakinnuma; Masayuki Kurosaki; Kentaro Matsuura; Minoru Sakamoto; Naoya Sakamoto; Fuminaka Sugauchi; Yoshiyuki Suzuki; Akihiro Tamori; Namiki Izumi
Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis.
Journal of gastroenterology 2011;46(9):1111-9.
2011: Masayuki Kurosaki; Namiki Izumi
[Prediction of response to peg-interferon plus ribavirin therapy for chronic hepatitis C].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2011;108(7):1170-8.
2011: Masayuki Kurosaki; Namiki Izumi
[Prediction of response to peginterferon and ribavirin therapy for chronic hepatitis C analyzed by data mining method].
Nihon rinsho. Japanese journal of clinical medicine 2011;69 Suppl 4():248-55.
2011: Naoya Sakamoto; Mina Nakagawa; Yasuhito Tanaka; Yuko Sekine-Osajima; Mayumi Ueyama; Masayuki Kurosaki; Nao Nishida; Akihiro Tamori; Nishimura-Sakurai Yuki; Yasuhiro Itsui; Seishin Azuma; Sei Kakinuma; Shuhei Hige; Yoshito Itoh; Eiji Tanaka; Yoichi Hiasa; Namiki Izumi; Katsushi Tokunaga; Masashi Mizokami; Mamoru Watanabe
Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b.
Journal of medical virology 2011;83(5):871-8.
2011: Jun Itakura; Yasuhiro Asahina; Nobuharu Tamaki; Itsuko Hirayama; Yutaka Yasui; Tomohiro Tanaka; Mitsuaki Sato; Ken Ueda; Teiji Kuzuya; Kaoru Tsuchiya; Hiroyuki Nakanishi; Masayuki Kurosaki; Gretchen S Gabriel; George J Schneider; Namiki Izumi
Changes in hepatitis C viral load during first 14 days can predict the undetectable time point of serum viral load by pegylated interferon and ribavirin therapy.
Hepatology research : the official journal of the Japan Society of Hepatology 2011;41(3):217-24.
2011: Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Suzuki; Naoki Hiramatsu; Fuminaka Sugauchi; Akihiro Tamori; Mina Nakagawa; Namiki Izumi
Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin: data mining analysis.
Journal of medical virology 2011;83(3):445-52.
2011: Masayuki Kurosaki; Yasuhito Tanaka; Nao Nishida; Naoya Sakamoto; Nobuyuki Enomoto; Masao Honda; Masaya Sugiyama; Kentaro Matsuura; Fuminaka Sugauchi; Yasuhiro Asahina; Mina Nakagawa; Mamoru Watanabe; Minoru Sakamoto; Shinya Maekawa; Akito Sakai; Shuichi Kaneko; Kiyoaki Ito; Naohiko Masaki; Katsushi Tokunaga; Namiki Izumi; Masashi Mizokami
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors.
Journal of hepatology 2011;54(3):439-48.
2011: Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Suzuki; Naoki Hiramatsu; Fuminaka Sugauchi; Hiroshi Yatsuhashi; Namiki Izumi
Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis.
Journal of gastroenterology 2011;46(3):401-9.
2011: Masayuki Kurosaki; Teiji Kuzuya; Kentaro Matsuura; Masashi Mizokami; Hiroyuki Nakanishi; Nao Nishida; Fuminaka Sugauchi; Yuichiro Suzuki; Yuka Takahashi; Nobuharu Tamaki; Keisuke Tanaka; Yasuhito Tanaka; Katsushi Tokunaga; Kaoru Tsuchiya; Ken Ueda; Yutaka Yasui; Yasuhiro Asahina; Nobuyuki Enomoto; Yoshihide Hoshioka; Takanori Hosokawa; Jun Itakura; Tomoji Kato; Namiki Izumi
Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirin.
Antiviral therapy 2011;16(5):685-94.
2011: Kaoru Tsuchiya; Ken Ueda; Yutaka Yasui; Yasuhiro Asahina; Nobuyuki Enomoto; Takanori Hosokawa; Jun Itakura; Mina Komuta; Masayuki Kurosaki; Teiji Kuzuya; Hiroyuki Nakanishi; Michiie Sakamoto; Yuka Takahashi; Nobuharu Tamaki; Namiki Izumi
Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
Oncology 2011;80(3-4):278-88.
2010: Yasuhiro Asahina; Kaoru Tsuchiya; Nobuharu Tamaki; Itsuko Hirayama; Tomohiro Tanaka; Mitsuaki Sato; Yutaka Yasui; Takanori Hosokawa; Ken Ueda; Teiji Kuzuya; Hiroyuki Nakanishi; Jun Itakura; Yuka Takahashi; Masayuki Kurosaki; Nobuyuki Enomoto; Namiki Izumi
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2010;52(2):518-27.
2010: Namiki Izumi; Yasuhiro Asahina; Masayuki Kurosaki
Predictors of virological response to a combination therapy with pegylated interferon plus ribavirin including virus and host factors.
Hepatitis research and treatment 2010;2010():703602.
2010: Jun Itakura; Masayuki Kurosaki; Yoshie Itakura; Sinya Maekawa; Yasuhiro Asahina; Namiki Izumi; Nobuyuki Enomoto
Reproducibility and usability of chronic virus infection model using agent-based simulation; comparing with a mathematical model.
Bio Systems 2010;99(1):70-8.
2008: Nobutoshi Komatsu; Masayuki Kurosaki; Mitsuaki Sato; Tomohiro Tanaka; Itsuko Hirayama; Yutaka Yasui; Naoki Umeda; Takanori Hosokawa; Ken Ueda; Kaoru Tuchiya; Hiroyuki Nakanishi; Jun Itakura; Yasuhiro Asahina; Hiroaki Akasaka; Koutarou Matsunaga; Kazuhiro Taki; Masamichi Kojiro; Namiki Izumi
[Epithelioid hemangioendothelioma of the liver diagnosed by laparoscopy guided biopsy].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2008;105(11):1640-7.
2008: Yasuhiro Asahina; Namiki Izumi; Itsuko Hirayama; Tomohiro Tanaka; Mitsuaki Sato; Yutaka Yasui; Nobutoshi Komatsu; Naoki Umeda; Takanori Hosokawa; Ken Ueda; Kaoru Tsuchiya; Hiroyuki Nakanishi; Jun Itakura; Masayuki Kurosaki; Nobuyuki Enomoto; Megumi Tasaka; Naoya Sakamoto; Shozo Miyake
Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response.
Gastroenterology 2008;134(5):1396-405.
2008: Masayuki Kurosaki; Kotaro Matsunaga; Itsuko Hirayama; Tomohiro Tanaka; Mitsuaki Sato; Nobutoshi Komatsu; Naoki Umeda; Takanori Hosokawa; Ken Ueda; Kaoru Tsuchiya; Hiroyuki Nakanishi; Jun Itakura; Yasuhiro Asahina; Shozo Miyake; Nobuyuki Enomoto; Namiki Izumi
The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy.
Journal of hepatology 2008;48(5):736-42.
2007: Namiki Izumi; Yasuhiro Asahina; Kaoru Tsuchiya; Masayuki Kurosaki; Hiroyuki Nakanishi; Takatoshi Kitamura; Masakatsu Uchihara; Schozo Miyake
Repeated radiofrequency ablation for the distant recurrence in the liver in patients with chronic hepatitis C virus infection achieving long-term survival.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37 Suppl 2():S254-63.
2007: Yasuhiro Asahina; Namiki Izumi; N Umeda; T Hosokawa; K Ueda; F Doi; K Tsuchiya; Hiroyuki Nakanishi; K Matsunaga; T Kitamura; Masayuki Kurosaki; Masakatsu Uchihara; M Higaki; Shozo Miyake
Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.
Journal of viral hepatitis 2007;14(6):396-403.
2006: Yasuhiro Itsui; Naoya Sakamoto; Masayuki Kurosaki; Nobuhiko Kanazawa; Yoko Tanabe; Tomoyuki Koyama; Yoshie Takeda; Mina Nakagawa; Sei Kakinuma; Yuko Sekine; Shinya Maekawa; Nobuyuki Enomoto; Mamoru Watanabe
Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
Journal of viral hepatitis 2006;13(10):690-700.
2006: Takahiro Kohashi; Shinya Maekawa; Naoya Sakamoto; Masayuki Kurosaki; Hidemi Watanabe; Yoko Tanabe; Cheng Hsin Chen; Nobuhiko Kanazawa; Mina Nakagawa; Sei Kakinuma; Tsuyoshi Yamashiro; Yasuhiro Itsui; Tomoyuki Koyama; Nobuyuki Enomoto; Mamoru Watanabe
Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication.
Journal of viral hepatitis 2006;13(9):582-90.
2006: Tsuyoshi Yamashiro; Naoya Sakamoto; Masayuki Kurosaki; Nobuhiko Kanazawa; Yoko Tanabe; Mina Nakagawa; Cheng-Hsin Chen; Yasuhiro Itsui; Tomoyuki Koyama; Yoshie Takeda; Shinya Maekawa; Nobuyuki Enomoto; Hiroshi Sakugawa; Mamoru Watanabe
Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3.
Journal of gastroenterology 2006;41(8):750-7.
2006: Masayuki Kurosaki; Namiki Izumi
Optimal timing of interferon treatment for acute hepatitis C.
Hepatology research : the official journal of the Japan Society of Hepatology 2006;34(1):1-2.
2005: Masayuki Kurosaki; Namiki Izumi; Yuko Onuki; Yuki Nishimura; Ken Ueda; Kaoru Tsuchiya; Hiroyuki Nakanishi; Takatoshi Kitamura; Yasuhiro Asahina; Masakatsu Uchihara; Shozo Miyake
Serum KL-6 as a novel tumor marker for hepatocellular carcinoma in hepatitis C virus infected patients.
Hepatology research : the official journal of the Japan Society of Hepatology 2005;33(3):250-7.
2005: Yasuhiro Asahina; Namiki Izumi; Nobuyuki Enomoto; Masakatsu Uchihara; Masayuki Kurosaki; Yuko Onuki; Yuki Nishimura; Ken Ueda; Kaoru Tsuchiya; Hiroyuki Nakanishi; Takatoshi Kitamura; Shozo Miyake
Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C.
Journal of hepatology 2005;43(4):623-9.
2005: Kosei Hamano; Naoya Sakamoto; Nobuyuki Enomoto; Namiki Izumi; Yasuhiro Asahina; Masayuki Kurosaki; Eri Ueda; Yoko Tanabe; Shinya Maekawa; Jun Itakura; Hideki Watanabe; Sei Kakinuma; Mamoru Watanabe
Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy.
Journal of gastroenterology and hepatology 2005;20(9):1401-9.
2005: Yoko Tanabe; Kazuyoshi Nagayama; Nobuyuki Enomoto; Namiki Izumi; Junichi Tazawa; Masayuki Kurosaki; Naoya Sakamoto; Chifumi Sato; Mamoru Watanabe
Characteristic sequence changes of hepatitis C virus genotype 2b associated with sustained biochemical response to IFN therapy.
Journal of viral hepatitis 2005;12(3):251-61.
2005: Hiroyuki Nakanishi; Masayuki Kurosaki; Yasuhiro Asahina; Yuko Onuki; Ken Ueda; Yuki Nishimura; Kaoru Tsuchiya; Takatoshi Kitamura; Masakatsu Uchihara; Shozo Miyake; Nobuyuki Enomoto; Namiki Izumi
Polymerase domain B mutation is associated with hepatitis relapse during long-term lamivudine therapy for chronic hepatitis B.
Intervirology 2005;48(6):381-8.
2005: Namiki Izumi; Asahina Yasuhiro; Masayuki Kurosaki; Yuko Onuki; Yuki Nishimura; Kazunari Inoue; Ken Ueda; Kaoru Tsuchiya; Hiroyuki Nakanishi; Masakatsu Uchihara; Shozo Miyake
Development of hepatocellular carcinoma after interferon therapy in chronic hepatitis C. Is it possible to reduce the incidence by ribanirin and IFN combination therapy?
Intervirology 2005;48(1):59-63.
2004: Shinya Maekawa; Nobuyuki Enomoto; Naoya Sakamoto; Masayuki Kurosaki; Eri Ueda; Takahiro Kohashi; Hidemi Watanabe; Cheng Hsin Chen; Tsuyoshi Yamashiro; Yoko Tanabe; Nobuhiko Kanazawa; Mina Nakagawa; Chifumi Sato; Mamoru Watanabe
Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells.
Journal of viral hepatitis 2004;11(5):394-403.
2004: Nobuhiko Kanazawa; Masayuki Kurosaki; Naoya Sakamoto; Nobuyuki Enomoto; Yasuhiro Itsui; Tsuyoshi Yamashiro; Yoko Tanabe; Shinya Maekawa; Mina Nakagawa; Cheng-Hsin Chen; Sei Kakinuma; Shigeru Oshima; Tetsuya Nakamura; Takanobu Kato; Takaji Wakita; Mamoru Watanabe
Regulation of hepatitis C virus replication by interferon regulatory factor 1.
Journal of virology 2004;78(18):9713-20.
2004: Masayuki Kurosaki; Namiki Izumi; Nobuyuki Enomoto
[Analysis of replicating hepatitis C virus quasispecies in hepatocellular carcinoma tissues].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 7(Pt 1):624-8.
2004: Yoko Tanabe; Naoya Sakamoto; Nobuyuki Enomoto; Masayuki Kurosaki; Eri Ueda; Shinya Maekawa; Tsuyoshi Yamashiro; Mina Nakagawa; Cheng-Hsin Chen; Nobuhiko Kanazawa; Sei Kakinuma; Mamoru Watanabe
Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
The Journal of infectious diseases 2004;189(7):1129-39.
2004: Mina Nakagawa; Naoya Sakamoto; Nobuyuki Enomoto; Yoko Tanabe; Nobuhiko Kanazawa; Tomoyuki Koyama; Masayuki Kurosaki; Shinya Maekawa; Tsuyoshi Yamashiro; Cheng Hsin Chen; Yasuhiro Itsui; Sei Kakinuma; Mamoru Watanabe
Specific inhibition of hepatitis C virus replication by cyclosporin A.
Biochemical and biophysical research communications 2004;313(1):42-7.
2004: Namiki Izumi; Yasuhiro Asahina; Masayuki Kurosaki; Masakatsu Uchihara; Yuki Nishimura; Kazunari Inoue; Ken Ueda; Kaoru Tsuchiya; Kousei Hamano; Jun Itakura; Shozo Miyake
A comparison of the exponential decay slope between PEG-IFN alfa-2b/ribavirin and IFN alfa-2b/ribavirin combination therapy in patients with chronic hepatitis C genotype 1b infection and a high viral load.
Intervirology 2004;47(2):102-7.
2003: Yuka Miyasaka; Nobuyuki Enomoto; Masayuki Kurosaki; Naoya Sakamoto; Nobuhiko Kanazawa; Takahiro Kohashi; Eri Ueda; Shinya Maekawa; Hideki Watanabe; Namiki Izumi; Chifumi Sato; Mamoru Watanabe
Hepatitis C virus nonstructural protein 5A inhibits tumor necrosis factor-alpha-mediated apoptosis in Huh7 cells.
The Journal of infectious diseases 2003;188(10):1537-44.
2001: Kazuyoshi Nagayama; Nobuyuki Enomoto; Y Miyasaka; Masayuki Kurosaki; C H Chen; Naoya Sakamoto; M Nakagawa; Chifumi Sato; Junichi Tazawa; T Ikeda; Namiki Izumi; M Watanabe
Overexpression of interferon gamma-inducible protein 10 in the liver of patients with type I autoimmune hepatitis identified by suppression subtractive hybridization.
The American journal of gastroenterology 2001;96(7):2211-7.
2001: Kazuyoshi Nagayama; Nobuyuki Enomoto; Namiki Izumi; Masayuki Kurosaki; Y Miyasaka; Hideki Watanabe; Jun Itakura; C H Chen; Junichi Tazawa; Y Hoshino; T Ikeda; Fumiaki Marumo; Chifumi Sato
Sequences in the NS5A protein of hepatitis C virus and the serum alanine aminotransferase response to interferon therapy in Japanese patients.
Gut 2001;48(6):830-5.
2000: K Nagayama; Masayuki Kurosaki; Nobuyuki Enomoto; Y Miyasaka; Fumiaki Marumo; Chifumi Sato
Characteristics of hepatitis C viral genome associated with disease progression.
Hepatology (Baltimore, Md.) 2000;31(3):745-50.
1999: Y Ogura; Masayuki Kurosaki; Yasuhiro Asahina; Nobuyuki Enomoto; Fumiaki Marumo; Chifumi Sato
Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus.
The Journal of infectious diseases 1999;180(5):1444-51.
1999: Kazuyoshi Nagayama; Masayuki Kurosaki; Nobuyuki Enomoto; Shinya Maekawa; Y Miyasaka; Junichi Tazawa; Namiki Izumi; Fumiaki Marumo; Chifumi Sato
Time-related changes in full-length hepatitis C virus sequences and hepatitis activity.
Virology 1999;263(1):244-53.
1999: T Murakami; Nobuyuki Enomoto; Masayuki Kurosaki; Namiki Izumi; Fumiaki Marumo; Chifumi Sato
Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection.
Hepatology (Baltimore, Md.) 1999;30(4):1045-53.
1999: I Sakuma; Nobuyuki Enomoto; Masayuki Kurosaki; Namiki Izumi; Fumiaki Marumo; Chifumi Sato
Differential effect of interferon on hepatitis C virus 1b quasispecies in the nonstructural protein 5A gene.
The Journal of infectious diseases 1999;180(4):1001-9.
1997: C Yamamoto; Nobuyuki Enomoto; Masayuki Kurosaki; S H Yu; Junichi Tazawa; Namiki Izumi; Fumiaki Marumo; Chifumi Sato
Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.
Hepatology (Baltimore, Md.) 1997;26(6):1616-20.
1997: Masayuki Kurosaki; Nobuyuki Enomoto; T Murakami; I Sakuma; Yasuhiro Asahina; C Yamamoto; T Ikeda; S Tozuka; Namiki Izumi; Fumiaki Marumo; Chifumi Sato
Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
Hepatology (Baltimore, Md.) 1997;25(3):750-3.
1996: Yasuhiro Asahina; Nobuyuki Enomoto; Y Ogura; Masayuki Kurosaki; I Sakuma; Namiki Izumi; Fumiaki Marumo; C Sato
Sequential changes in full-length genomes of hepatitis B virus accompanying acute exacerbation of chronic hepatitis B.
Journal of hepatology 1996;25(6):787-94.
1996: Masayuki Kurosaki; Nobuyuki Enomoto; Yasuhiro Asahina; I Sakuma; T Ikeda; S Tozuka; Namiki Izumi; Fumiaki Marumo; C Sato
Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B.
Journal of medical virology 1996;49(2):115-23.
1996: Yasuhiro Asahina; Nobuyuki Enomoto; Y Ogura; I Sakuma; Masayuki Kurosaki; Namiki Izumi; Fumiaki Marumo; C Sato
Complete nucleotide sequences of hepatitis B virus genomes associated with epidemic fulminant hepatitis.
Journal of medical virology 1996;48(2):171-8.
1996: Nobuyuki Enomoto; I Sakuma; Yasuhiro Asahina; Masayuki Kurosaki; T Murakami; C Yamamoto; Y Ogura; Namiki Izumi; Fumiaki Marumo; C Sato
Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
The New England journal of medicine 1996;334(2):77-81.
1995: I Sakuma; Nobuyuki Enomoto; Yasuhiro Asahina; Masayuki Kurosaki; C Sato
[Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b].
Nihon rinsho. Japanese journal of clinical medicine 1995;53 Suppl(Pt 1):930-5.
1995: Masayuki Kurosaki; Nobuyuki Enomoto; N Sakamoto; C Sato
[Analysis of replicating hepatitis C virus quasispecies in hepatocellular carcinoma tissues using PCR-SSCP method].
Nihon rinsho. Japanese journal of clinical medicine 1995;53 Suppl(Pt 1):796-9.
1995: Yasuhiro Asahina; Nobuyuki Enomoto; Masayuki Kurosaki; I Sakuma; C Sato
[Sequential analysis of the hypervariable region of the hepatitis C virus genome in acute infection].
Nihon rinsho. Japanese journal of clinical medicine 1995;53 Suppl(Pt 1):500-4.
1995: Masayuki Kurosaki; Nobuyuki Enomoto; C Sato
[Analysis of hepatitis C virus quasispecies populations using PCR-SSCP method].
Nihon rinsho. Japanese journal of clinical medicine 1995;53 Suppl(Pt 1):339-45.
1995: Masayuki Kurosaki; Nobuyuki Enomoto; T Nouchi; I Sakuma; Fumiaki Marumo; C Sato
Fraction-specific populations of the hypervariable region of the hepatitis C virus in a patient with cryoglobulinemia.
Journal of medical virology 1995;46(4):403-8.
1995: Y Hoshino; Nobuyuki Enomoto; Namiki Izumi; Masayuki Kurosaki; Fumiaki Marumo; C Sato
Limited usage of T-cell receptor beta chains and sequences of the complementarity determining region 3 of lymphocytes infiltrating in the liver of autoimmune hepatitis.
Hepatology (Baltimore, Md.) 1995;22(1):142-7.
1995: Nobuyuki Enomoto; I Sakuma; Yasuhiro Asahina; Masayuki Kurosaki; T Murakami; C Yamamoto; Namiki Izumi; Fumiaki Marumo; C Sato
Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.
The Journal of clinical investigation 1995;96(1):224-30.
1995: K Koizumi; Nobuyuki Enomoto; Masayuki Kurosaki; T Murakami; Namiki Izumi; Fumiaki Marumo; C Sato
Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment.
Hepatology (Baltimore, Md.) 1995;22(1):30-5.
1995: Masayuki Kurosaki; Nobuyuki Enomoto; N Sakamoto; Y Tanaka; L Tang; Y Hoshino; Namiki Izumi; Fumiaki Marumo; C Sato
Detection and analysis of replicating hepatitis C virus RNA in hepatocellular carcinoma tissues.
Journal of hepatology 1995;22(5):527-35.
1995: N Sakamoto; Nobuyuki Enomoto; Masayuki Kurosaki; Yasuhiro Asahina; S Maekawa; K Koizumi; I Sakuma; T Murakami; Fumiaki Marumo; C Sato
Comparison of the hypervariable region of hepatitis C virus genomes in plasma and liver.
Journal of medical virology 1995;46(1):7-11.
1994: Masayuki Kurosaki; Nobuyuki Enomoto; F Marumo; C Sato
Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C.
Virology 1994;205(1):161-9.
1994: Nobuyuki Enomoto; Masayuki Kurosaki; K Koizumi; Yasuhiro Asahina; I Sakuma; T Murakami; C Yamamoto; Fumiaki Marumo; C Sato
[Fluctuation of HCV quasi-species population during interferon therapy; analysis by single strand conformation polymorphism].
Nihon rinsho. Japanese journal of clinical medicine 1994;52(7):1707-15.
1994: Nobuyuki Enomoto; Masayuki Kurosaki; Y Tanaka; Fumiaki Marumo; C Sato
Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis.
The Journal of general virology 1994;75 ( Pt 6)():1361-9.
1994: N Sakamoto; Nobuyuki Enomoto; Masayuki Kurosaki; Fumiaki Marumo; C Sato
Detection and quantification of hepatitis C virus RNA replication in the liver.
Journal of hepatology 1994;20(5):593-7.
1994: Nobuyuki Enomoto; C Sato; Masayuki Kurosaki; Fumiaki Marumo
Hepatitis C virus after interferon treatment has the variation in the hypervariable region of envelope 2 gene.
Journal of hepatology 1994;20(2):252-61.
1994: N Sakamoto; Nobuyuki Enomoto; Masayuki Kurosaki; Fumiaki Marumo; C Sato
Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection.
Journal of medical virology 1994;42(1):103-8.
1993: Masayuki Kurosaki; Nobuyuki Enomoto; Fumiaki Marumo; C Sato
Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection.
Hepatology (Baltimore, Md.) 1993;18(6):1293-9.
1993: Masayuki Kurosaki; Nobuyuki Enomoto; C Sato; N Sakamoto; Y Hoshino; H Haritani; Fumiaki Marumo
Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non-A, non-B chronic liver disease.
Journal of medical virology 1993;39(3):246-50.
1993: N Sakamoto; C Sato; H Haritani; S Maekawa; Masayuki Kurosaki; Nobuyuki Enomoto; Y Hoshino; Junichi Tazawa; M Nishimura; Fumiaki Marumo
Detection of hepatitis C viral RNA in sporadic acute non-A, non-B hepatitis by polymerase chain reaction. Its usefulness for the early diagnosis of seronegative infection.
Journal of hepatology 1993;17(1):28-33.